Home/Filings/4/0001193805-23-001629
4//SEC Filing

Chivukula Pad 4

Accession 0001193805-23-001629

CIK 0001768224other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 8:01 PM ET

Size

5.8 KB

Accession

0001193805-23-001629

Insider Transaction Report

Form 4
Period: 2023-12-15
Chivukula Pad
Chief Scientific Officer & COO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-12-15+125,000125,000 total
    Exercise: $28.88Exp: 2033-12-15Common Stock (125,000 underlying)
Footnotes (2)
  • [F1]Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
  • [F2]The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.

Issuer

Arcturus Therapeutics Holdings Inc.

CIK 0001768224

Entity typeother

Related Parties

1
  • filerCIK 0001727317

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 8:01 PM ET
Size
5.8 KB